• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SeaWorld Entertainment Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits

    1/26/24 4:15:14 PM ET
    $SEAS
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care
    Get the next $SEAS alert in real time by email
    8-K
    0001564902false00015649022024-01-222024-01-22

     

    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    WASHINGTON, D.C. 20549

     

    FORM 8-K

     

    CURRENT REPORT

    Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

    Date of Report (Date of earliest event reported): January 22, 2024

     

     

    SeaWorld Entertainment, Inc.

    (Exact name of Registrant as Specified in Its Charter)

     

     

    Delaware

    001-35883

    27-1220297

    (State or Other Jurisdiction
    of Incorporation)

    (Commission File Number)

    (IRS Employer
    Identification No.)

     

     

     

     

     

    6240 Sea Harbor Drive

     

    Orlando, Florida

     

    32821

    (Address of Principal Executive Offices)

     

    (Zip Code)

     

    Registrant’s Telephone Number, Including Area Code: 407 226-5011

     

     

    (Former Name or Former Address, if Changed Since Last Report)

     

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

    ☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    ☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    ☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    ☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    Securities registered pursuant to Section 12(b) of the Act:


    Title of each class

     

    Trading
    Symbol(s)

     


    Name of each exchange on which registered

    Common Stock, par value $0.01 per share

     

    SEAS

     

    New York Stock Exchange

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

    Emerging growth company ☐

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     


    Item 1.01 Entry into a Material Definitive Agreement.

    On January 22, 2024, SeaWorld Parks & Entertainment, Inc. entered into an amendment (the “Amendment”) for its existing first lien term loan facility under that certain Amended and Restated Credit Agreement, dated as of August 25, 2021 (and as amended on June 9, 2022 and June 12, 2023), among SeaWorld Entertainment, Inc. (the “Company”), SeaWorld Parks & Entertainment, Inc., the lenders party thereto and JPMorgan Chase Bank, N.A., as administrative agent and collateral agent.

    After giving effect to the Amendment, including the incurrence of an aggregate principal amount of approximately $1.173 million of Term B-2 Loans under the Credit Agreement (the “New Term Loans”) to refinance the existing Term B Loans under the Credit Agreement (the “Term B Loans”), the New Term Loans will be subject to the same affirmative and negative covenants and events of default as the Term B Loans.

    Borrowings under the New Term Loans bear interest at a fluctuating rate per annum equal to, at the Borrower’s option, (i) ABR (provided that in no event shall such ABR rate with respect to the New Term Loans be less than 1.50% per annum) plus an applicable margin equal to 1.50% or (ii) Adjusted Term SOFR (provided that in no event shall such Adjusted Term SOFR rate with respect to the New Term Loans be less than 0.50%) plus an applicable margin equal to 2.50%.

    The New Term Loans require scheduled amortization payments on the term loans in quarterly amounts equal to 0.25% of the original principal amount of the New Term Loans, payable quarterly, with the balance to be paid at maturity on August 25, 2028.

    The lenders under the New Term Loans and their respective affiliates have in the past engaged, and may in the future engage, in transactions with and perform services, including commercial banking, financial advisory and investment banking services, for the Company and its affiliates in the ordinary course of business for which they have received or will receive customary fees and expenses.

    This summary is qualified in its entirety by reference to the full text of the Amendment, filed as Exhibit 10.1 to this Current Report on Form 8-K (this “Current Report”) and incorporated herein by reference.

    Item 2.03 Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.

    The information provided in Item 1.01 of this Current Report is incorporated by reference herein.

    Item 9.01 Financial Statements and Exhibits.

    (d) Exhibits

    Exhibit No.

    Description

    10.1

    Amendment No. 2, dated as January 22, 2024, to the Amended and Restated Credit Agreement, dated as of August 25, 2021, by and among SeaWorld Parks & Entertainment, Inc., SeaWorld Entertainment, Inc., the subsidiary guarantors party thereto, the lenders party thereto and JPMorgan Chase Bank, N.A., as Administrative Agent and as Collateral Agent.

    104

    Cover page interactive data filed (embedded within the Inline XBRL document).

     

    Forward Looking Statements

    This report contains statements relating to future results (including certain projections and business trends) that are “forward-looking statements” within the meaning of the federal securities laws. The Company generally uses the words such as “might,” “will,” “may,” “should,” “estimates,” “expects,” “continues,” “contemplates,” “anticipates,” “projects,” “plans,” “potential,” “predicts,” “intends,” “believes,” “forecasts,” “future,” “targeted,” “goal” and variations of such words or similar expressions in this report and any attachment to identify forward-looking statements. All statements, other than statements of historical facts included in this report, including statements concerning plans, objectives, goals, expectations, beliefs, business strategies, future events, business conditions, results of operations, financial position, business outlook, earnings guidance, business trends and other information are forward-looking statements. The forward-looking statements are not historical facts, and are based upon the Company’s current expectations, beliefs, estimates and projections, and various assumptions, many of which, by their nature, are inherently uncertain and beyond management’s control.

    All expectations, beliefs, estimates and projections are expressed in good faith and the Company believes there is a reasonable basis for them. However, there can be no assurance that management’s expectations, beliefs, estimates and projections will result or be achieved and actual results may vary materially from what is expressed in or indicated by the forward-looking statements.

    These forward-looking statements are subject to a number of risks, uncertainties and other important factors, many of which are beyond management’s control, that could cause actual results to differ materially from the forward-looking statements contained in this report, including among others: a decline in discretionary consumer spending or consumer confidence, including any unfavorable impacts from Federal Reserve interest rate actions and inflation which may influence discretionary spending, unemployment or the


    overall economy; various factors beyond the Company’s control adversely affecting attendance and guest spending at its theme parks, including, but not limited to, weather, natural disasters, labor shortages, inflationary pressures, supply chain delays or shortages, foreign exchange rates, consumer confidence, the potential spread of travel-related health concerns including pandemics and epidemics, travel related concerns, adverse general economic related factors including increasing interest rates, economic uncertainty, and recent geopolitical events outside of the United States, and governmental actions; failure to hire and/or retain employees; increased labor costs, including minimum wage increases, and employee health and welfare benefit costs; complex federal and state regulations governing the treatment of animals, which can change, and claims and lawsuits by activist groups before government regulators and in the courts; activist and other third-party groups and/or media can pressure governmental agencies, vendors, partners, guests and/or regulators, bring action in the courts or create negative publicity about us; incidents or adverse publicity concerning the Company’s theme parks, the theme park industry and/or zoological facilities; a significant portion of the Company’s revenues have historically been generated in the States of Florida, California and Virginia, and any risks affecting such markets, such as natural disasters, closures due to pandemics, severe weather and travel-related disruptions or incidents; technology interruptions or failures that impair access to the Company’s websites and/or information technology systems; cyber security risks to the Company or the Company third-party service providers, failure to maintain or protect the integrity of internal, employee or guest data, and/or failure to abide by the evolving cyber security regulatory environment; inability to compete effectively in the highly competitive theme park industry; interactions between animals and the Company’s employees and it’s guests at attractions at the Company’s theme parks; animal exposure to infectious disease; high fixed cost structure of theme park operations; seasonal fluctuations in operating results; changing consumer tastes and preferences; inability to remediate an identified material weakness on a timely basis; inability to grow the Company’s business or fund theme park capital expenditures; inability to realize the benefits of developments, restructurings, acquisitions or other strategic initiatives, and the impact of the costs associated with such activities; the effects of the global Coronavirus pandemic, or any related mutations of the virus on the Company’s business and the economy in general; adverse litigation judgments or settlements; inability to protect the Company’s intellectual property or the infringement on intellectual property rights of others; the loss of licenses and permits required to exhibit animals or the violation of laws and regulations; unionization activities and/or labor disputes; inability to maintain certain commercial licenses; restrictions in the Company’s debt agreements limiting flexibility in operating the Company’s business; inability to retain the Company’s current credit ratings; the Company’s leverage and interest rate risk; the ability of Hill Path Capital LP and its affiliates to significantly influence the Company’s decisions and their interests may conflict with the Company or yours in the future; inadequate insurance coverage; inability to purchase or contract with third party manufacturers for rides and attractions, construction delays or impacts of supply chain disruptions on existing or new rides and attractions; environmental regulations, expenditures and liabilities; suspension or termination of any of the Company’s business licenses, including by legislation at federal, state or local levels; delays, restrictions or inability to obtain or maintain permits; financial distress of strategic partners or other counterparties; tariffs or other trade restrictions; actions of activist stockholders; the policies of the U.S. President and his administration or any changes to tax laws; changes or declines in the Company’s stock price, as well as the risk that securities analysts could downgrade the Company’s stock or the Company’s sector; risks associated with the Company’s capital allocation plans and share repurchases, including the risk that the Company’s share repurchase program could increase volatility and fail to enhance stockholder value and other risks, uncertainties and factors set forth in the section entitled “Risk Factors” in the Company’s most recently available Annual Report on Form 10-K, as such risks, uncertainties and factors may be updated in the Company’s periodic filings with the Securities and Exchange Commission. Although the Company believes that these statements are based upon reasonable assumptions, it cannot guarantee future results and readers are cautioned not to place undue reliance on these forward-looking statements, which reflect management’s opinions only as of the date of this report.

    There can be no assurance that (i) the Company has correctly measured or identified all of the factors affecting its business or the extent of these factors’ likely impact, (ii) the available information with respect to these factors on which such analysis is based is complete or accurate, (iii) such analysis is correct or (iv) the Company’s strategy, which is based in part on this analysis, will be successful. Except as required by applicable law, the Company undertakes no obligation to update any forward-looking statement, whether as a result of new information, future developments or otherwise.


    SIGNATURES

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     

     

     

    SEAWORLD ENTERTAINMENT, INC.

     

     

     

     

    Date:

    January 26, 2024

    By:

    /s/ G. Anthony (Tony) Taylor

     

     

    Name:

    Title:

    G. Anthony (Tony) Taylor
    Chief Legal Officer, General Counsel and Corporate Secretary

     


    Get the next $SEAS alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $SEAS

    DatePrice TargetRatingAnalyst
    12/14/2023$60.00 → $57.00Overweight → Equal-Weight
    Morgan Stanley
    11/1/2023$67.00 → $57.00Neutral
    JP Morgan
    7/24/2023$75.00 → $66.00Buy
    Goldman
    5/31/2023$75.00Buy
    Goldman
    5/25/2023Sector Weight
    KeyBanc Capital Markets
    4/20/2023$70.00Overweight
    Morgan Stanley
    7/13/2022Overweight → Sector Weight
    KeyBanc Capital Markets
    4/26/2022$92.00Buy
    Rosenblatt
    More analyst ratings

    $SEAS
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • SeaWorld Entertainment downgraded by Morgan Stanley with a new price target

      Morgan Stanley downgraded SeaWorld Entertainment from Overweight to Equal-Weight and set a new price target of $57.00 from $60.00 previously

      12/14/23 7:48:37 AM ET
      $SEAS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • JP Morgan resumed coverage on SeaWorld Entertainment with a new price target

      JP Morgan resumed coverage of SeaWorld Entertainment with a rating of Neutral and set a new price target of $57.00 from $67.00 previously

      11/1/23 6:19:32 AM ET
      $SEAS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Goldman reiterated coverage on SeaWorld Entertainment with a new price target

      Goldman reiterated coverage of SeaWorld Entertainment with a rating of Buy and set a new price target of $66.00 from $75.00 previously

      7/24/23 10:10:47 AM ET
      $SEAS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care

    $SEAS
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • SeaWorld San Antonio Reveals Plans for the ALL-NEW Rescue Jr. Hub, a Kid-Friendly World of Discovery Packed with Interactive Play, Immersive Attractions and a One-Of-A-Kind Water Elements - Opening Spring 2025

      2025 Annual Passes are now available with the best benefits ever, including Aquatica for free, free parking, free guest tickets, in-park discounts and exclusive animal experiences; 2025 Annual Pass Members will also be the first to experience Rescue Jr. DOWNLOAD HIGH-RES IMAGES HERE  SAN ANTONIO, Sept. 30, 2024 /PRNewswire/ -- SeaWorld San Antonio today unveiled its plans for an ALL-NEW friendly world of discovery, the Rescue Jr. hub, set to open Spring 2025. This immersive, hands-on adventure zone will transport young guests into the heart of SeaWorld's animal rescue efforts, where they'll tackle immersive rides, conquer towering climbing structures, splash through vibrant water features a

      9/30/24 9:00:00 AM ET
      $PRKS
      $SEAS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Get Ready for Jaw-Dropping Adventures as SeaWorld's Ultimate Shark Experience Returns for 2024

      SeaWorld's week-long Ultimate Shark Experience celebrates sharks in its parks with once-in-a-lifetime fin-credible opportunities for guests of all ages, all while supporting shark conservation DOWNLOAD HIGH-RES IMAGES HERE ORLANDO, Fla., July 2, 2024 /PRNewswire/ -- SeaWorld is thrilled to unveil the return of its highly anticipated Ultimate Shark Experience ticket, available for purchase starting today. This special ticket provides guests with an exclusive opportunity to fully immerse themselves in a day filled with exciting and educational shark-focused activities. From goin

      7/2/24 8:00:00 AM ET
      $PRKS
      $SEAS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SeaWorld and Coca-Cola Say Cheers to 60 Years with New Celebration Sundays Featuring Exclusive Merchandise Giveaways for Pass Members and Complimentary Beverage Sampling for All Guests

      Coca-Cola Celebration Sundays at SeaWorld start Sunday, June 16th and continue the third Sunday of each month for the rest of the year ORLANDO, Fla., June 13, 2024 /PRNewswire/ -- Coca-Cola is toasting SeaWorld's 60th anniversary by partnering with the parks to host "Celebration Sundays," featuring free beverage sampling for all guests and exclusive, limited-edition co-branded merchandise giveaways for pass members, while supplies last. The events kick-off on Sunday, June 16 and will continue on the third Sunday of each month through the end of the year. Each month's merchandise giveaway will be a new collectible item that will be announced prior to that month's event. June's giveaway is a 2

      6/13/24 8:00:00 AM ET
      $PRKS
      $SEAS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care

    $SEAS
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Lipman Nathaniel was granted 1,687 shares (SEC Form 4)

      4 - SeaWorld Entertainment, Inc. (0001564902) (Issuer)

      1/4/24 4:46:38 PM ET
      $SEAS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SEC Form 3 filed by new insider Lipman Nathaniel

      3 - SeaWorld Entertainment, Inc. (0001564902) (Issuer)

      1/4/24 4:42:26 PM ET
      $SEAS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Hill Path Capital Partners Co-Investment S Lp was granted 1,902 shares (SEC Form 4)

      4 - SeaWorld Entertainment, Inc. (0001564902) (Issuer)

      1/3/24 4:51:05 PM ET
      $SEAS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care

    $SEAS
    SEC Filings

    See more
    • SeaWorld Entertainment Inc. filed SEC Form 8-K: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits

      8-K - United Parks & Resorts Inc. (0001564902) (Filer)

      2/13/24 4:16:14 PM ET
      $SEAS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SeaWorld Entertainment Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits (Amendment)

      8-K/A - SeaWorld Entertainment, Inc. (0001564902) (Filer)

      1/29/24 6:30:11 AM ET
      $SEAS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SeaWorld Entertainment Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits

      8-K - SeaWorld Entertainment, Inc. (0001564902) (Filer)

      1/26/24 4:15:14 PM ET
      $SEAS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care

    $SEAS
    Leadership Updates

    Live Leadership Updates

    See more
    • SeaWorld Launches 60th Anniversary Celebrations and Unveils "There's So Much More to Sea"

      Guests are invited to take advantage of limited time promotions on tickets and passes to join the celebrations, which kick off on March 21 with in-park parties and continue with thrilling new rides, shows and experiences coming this summer DOWNLOAD HIGH-RES IMAGES HERE ORLANDO, Fla., Feb. 5, 2024 /PRNewswire/ -- SeaWorld is turning 60 this year, and to celebrate, the world-class parks are throwing a party and marking the occasion throughout the year with all-new themed rides and attractions, exciting new presentations and shows, and plenty of other exclusive ticket and experience offers, plus limited-edition food and beverage items, merchandise and collectibles that will be announced in the

      2/5/24 8:00:00 AM ET
      $SEAS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SeaWorld to Open Exciting One-Of-A-Kind Marine Life Themed Rides and Experiences for the Whole Family in Every Park in 2024

      Become a 2024 Pass Member and be the first to experience the new attractions before they open to the public; 2024 passes on sale now DOWNLOAD MEDIA ASSETS HERE ORLANDO, Fla., Sept. 28, 2023 /PRNewswire/ -- SeaWorld is thrilled to announce it will open one-of-a-kind marine life themed rides and attractions in every SeaWorld park in Spring 2024.  Guests to the award-winning parks in Orlando, San Antonio, and San Diego can look forward to epic journeys and experiences for the whole family that will leave them breathless, drenched, and utterly mesmerized.  Attractions include "Penguin Trek" at SeaWorld Orlando, an all-new family friendly coaster for guests 42-77 inches in height that will transp

      9/28/23 9:00:00 AM ET
      $SEAS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SeaWorld Entertainment, Inc. Announces the Retirement of Michelle ("Chelle") Adams

      ORLANDO, Fla., July 3, 2023 /PRNewswire/ -- SeaWorld Entertainment, Inc. (NYSE:SEAS), a leading theme park and entertainment company, today announced that Chelle Adams, Chief Transformation Officer of SeaWorld Entertainment, Inc., intends to retire from SeaWorld in order to pursue personal opportunities effective August 4th, 2023. Ms. Adams will be available to the company over the coming months to ensure a smooth transition.  Marc Swanson, Chief Executive Officer of SeaWorld Entertainment, Inc. said, "On behalf of the entire Company, we want to thank Chelle for her contributions to the Company and wish her well." Chelle Adams said, "I appreciate the opportunity to have been part of the SeaW

      7/3/23 4:50:00 PM ET
      $SEAS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care

    $SEAS
    Financials

    Live finance-specific insights

    See more
    • SEAWORLD ENTERTAINMENT, INC. ANNOUNCES FOURTH QUARTER AND FISCAL 2023 EARNINGS RELEASE DATE AND CONFERENCE CALL INFORMATION

      ORLANDO, Fla., Feb. 8, 2024 /PRNewswire/ -- SeaWorld Entertainment, Inc. (NYSE:SEAS) announced today that it will release its fourth quarter and fiscal 2023 financial results before the market opens on Wednesday, February 28, 2024. In conjunction with the release, the Company has scheduled a conference call, which will be broadcast live over the internet on Wednesday, February 28, 2024, at 9 a.m. Eastern Time. The release and the conference call can be accessed via the Company's website at www.SeaWorldInvestors.com or www.UnitedParksInvestors.com. For those unable to participate in the live webcast, a replay will be available beginning at approximately 12 p.m. Eastern Time on February 28, 20

      2/8/24 4:30:00 PM ET
      $SEAS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SEAWORLD ENTERTAINMENT, INC. ANNOUNCES THIRD QUARTER EARNINGS RELEASE DATE AND CONFERENCE CALL INFORMATION

      ORLANDO, Fla., Oct. 11, 2023 /PRNewswire/ -- SeaWorld Entertainment, Inc. (NYSE:SEAS) announced today that it will release its third quarter financial results before the market opens on Wednesday, November 8, 2023. In conjunction with the release, the Company has scheduled a conference call, which will be broadcast live over the internet on Wednesday, November 8, 2023, at 9 a.m. Eastern Time. The release and the conference call can be accessed via the Company's website at www.SeaWorldInvestors.com. For those unable to participate in the live webcast, a replay will be available beginning at approximately 12 p.m. Eastern Time on November 8, 2023, under the "Events & Presentations" tab of www.S

      10/11/23 6:30:00 AM ET
      $SEAS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SeaWorld Entertainment, Inc. Reports Second Quarter and First Six Months 2023 Results

      ORLANDO, Fla., Aug. 8, 2023 /PRNewswire/ -- SeaWorld Entertainment, Inc. (NYSE:SEAS), a leading theme park and entertainment company, today reported its financial results for the second quarter and first six months of fiscal year 2023. Second Quarter 2023 Highlights Attendance was 6.1 million guests, a decrease of approximately 0.1 million guests from the second quarter of 2022.Total revenue was $496.0 million, a decrease of $8.8 million or 1.7% from the second quarter of 2022.Net income was $87.1 million, a decrease of $29.6 million or 25.3% from the second quarter of 2022.Adjusted EBITDA[1] was $224.2 million, a decrease of $10.2 million or 4.4% from the second quarter of 2022.Total revenu

      8/8/23 6:30:00 AM ET
      $SEAS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care

    $SEAS
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by SeaWorld Entertainment Inc.

      SC 13G - United Parks & Resorts Inc. (0001564902) (Subject)

      2/13/24 1:09:05 PM ET
      $SEAS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SEC Form SC 13G/A filed by SeaWorld Entertainment Inc. (Amendment)

      SC 13G/A - SeaWorld Entertainment, Inc. (0001564902) (Subject)

      2/14/23 10:41:02 AM ET
      $SEAS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SEC Form SC 13D/A filed by SeaWorld Entertainment Inc. (Amendment)

      SC 13D/A - SeaWorld Entertainment, Inc. (0001564902) (Subject)

      11/14/22 4:02:56 PM ET
      $SEAS
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care